Maravai LifeSciences Holdings Inc Ordinary Shares - Class A (MRVI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$3.50

Buy

$3.70

arrow-down$-0.08 (-2.18%)

Prices updated at 17 Dec 2025, 00:43 EST

Prices minimum 15 mins delay

Prices in USD

NASDAQ

0.23%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	289m	259m
	140m	108m
	-28m	-73m
	-9.85	-28.04
	-119m	-145m
	712m	-157m
Sales, General and administrative	151m	162m
Interest expenses	46m	48m
Provision for income taxes	756m	-2m
Operating expenses	169m	181m
Income before taxes	618m	-261m
Net income available to common shareholders	-119m	-145m
	-0.9	-1.05
Net interest income	-18m	-20m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.9	-1.05
Free cash flow per share	1.0005	-0.0865
Book value/share	3.9273	2.431
Debt equity ratio	1.435176	1.115856

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	700m	429m
Current liabilities	87m	57m
Total capital	935m	616m
Total debt	611m	377m
Total equity	417m	325m
Total non current liabilities	-	-
Loans	519m	290m
Total assets	1,487m	1,008m
Total liabilities	-	-
Cash and cash equivalents	575m	322m
Common stock	132m	142m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	632m	575m
Cash dividends paid	-	-
	61m	-24m
Investments (gains) losses	-122m	-24m
	575m	322m
Net income	-	-
	126m	7m
	-66m	-31m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.